Over the last several decades, the Food and Drug Administration has allowed pharma companies to sell hundreds of drugs to patients without adequate evidence that they work and, in many cases, with clear signs that they pose a risk of serious harm.
Over the last several decades, the Food and Drug Administration has allowed pharma companies to sell hundreds of drugs to patients without adequate evidence that they work and, in many cases, with clear signs that they pose a risk of serious harm.
In 2023, the pharmaceutical industry spent $383 million on federal lobbying, more than all other industries same in 2024.
Pharmaceutical companies have always spent more on lobbying, spending over $6.3 billion from 1998 to 2025